Blue Jet Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-2.5%1-day move

₹483.90

prior close

₹511.45

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.2-0.1-0.1-0.1-2.5-6.3-7.7-6.1-7.4-4.0+4.3+6.5+19.7—

Up moveDown movePending

AI summary

Blue Jet Healthcare published its audited standalone financial results for Q4 FY26 and the full year ended March 31, 2026, in Financial Express and Navshakti on May 26, 2026. Total revenue from operations for FY26 stood at Rs. 162.41 crore, up from Rs. 156.16 crore in FY25. Net profit for the full year was Rs. 155.32 crore, compared to Rs. 150.49 crore in the prior year, representing a ~3.2% YoY increase. Basic EPS improved to Rs. 1.87 from Rs. 1.50. For Q4 standalone, revenue was Rs. 88.10 crore and net profit was Rs. 84.51 crore. The statutory auditors certified the results on May 27, 2026, and the full details are available on BSE's website.

Likely market impact

The company reported modest YoY growth in both revenue and net profit for FY26, with a notable improvement in EPS. The Q4 standalone revenue was strong at Rs. 88 crore, suggesting momentum in the final quarter, which could be viewed positively by investors.